B2M and Miyoshi myopathy: Disease stage, using ISS staging based on beta 2-microglobulin and albumin levels in the blood has been shown to be a reproducible predictor of MM survival.40 Therefore, ISS disease stage was used to determine any correlation between disease stage, mutation burden, and PFS.